What is COPD?
COPD – in full, chronic obstructive pulmonary disease – is a slowly progressive, chronic lung disease that makes breathing difficult. The essence of the disease is that the airways narrow and the lungs’ air reserves decrease. There are two main forms: chronic bronchitis, where the bronchial mucosa is chronically inflamed and produces excessive mucus, and emphysema, where the small air sacs in the lungs (alveoli) are damaged.
The most common cause is smoking – about 80–90% of people with COPD are current or former smokers. It can also be caused by air pollution, inhalation of workplace dust and chemicals, or, less commonly, genetic factors. If you smoke and have COPD, the most important step you can take is to quit. This won’t cure existing damage, but it can halt further decline.
Key point
COPD is a chronic, slowly progressive lung disease, most commonly caused by smoking. The disease is not curable, but with appropriate treatment symptoms can be controlled and progression slowed.
Symptoms of COPD
The disease begins slowly and often goes unnoticed. For a long time you may think you just have a “smoker’s cough” or that you’re simply getting older. Warning signs include a persistent cough, especially in the morning, when thick, hard-to-clear mucus is produced. Shortness of breath initially occurs only with heavier physical exertion, but later can appear during everyday activities—walking, getting dressed, talking.
As the disease progresses, symptoms worsen. Typical signs include chest tightness, wheezing, and the so‑called “barrel chest,” when the front‑to‑back diameter of the chest increases. During acute exacerbations symptoms suddenly get worse and hospitalization is often required.
How is COPD treated?
COPD is not curable, but with appropriate treatment symptoms can be controlled and disease progression slowed. Basic treatment consists of bronchodilator inhalers that help widen narrowed airways. In more severe cases, anti‑inflammatory steroid inhalers are used. In acute exacerbations, antibiotics and oral steroids may be necessary.
Pulmonary rehabilitation—which includes breathing exercises, conditioning exercise, and education—has been proven to improve quality of life and exercise capacity in people with COPD. In advanced cases, oxygen therapy may be required. This is where complementary therapies, including salt therapy, come into play.
What is salt therapy and how does it work in COPD?
Salt therapy—or halotherapy—is a natural method based on inhaling salty air. The idea is that you breathe in tiny, micron‑sized salt particles that penetrate deep into the airways and have beneficial effects on lung function. You can learn more in the article Salt Therapy and Halotherapy: A Guide to Airway Health.
According to information from the Department of Otorhinolaryngology at Semmelweis University, the size of salt particles determines how far they reach in the airways.1 Particles between 0.5 and 5 microns reach the lower airways, down to the bronchi—which is key for COPD, since the disease causes its main problems there.
How can salt therapy affect COPD?
The mechanism works on several levels.
Salt particles, by their osmotic effect, attract water to the airway mucosa. As a result, the thick, sticky mucus—one of the biggest problems for people with COPD—thins out and becomes easier to cough up. Think of trying to rinse a jar of honey with cold water—it’s hard. But if the honey is diluted, it washes away easily. Salt therapy does the same to airway mucus.
Salt has an anti‑inflammatory effect. Recent research shows that halotherapy inhibits activation of the so‑called NLRP3 inflammasome—a key inflammatory pathway in COPD.2 A 2023 Chinese animal study found that salt therapy reduced levels of inflammatory factors (TNF‑α, IL‑1β) and improved lung function in rats with COPD.2
Salt therapy may help the function of airway cilia. These tiny hairs are responsible for sweeping inhaled contaminants and mucus out of the lungs. In COPD these cilia are damaged and slowed. Salt therapy can help restore their function—this is called improving mucociliary clearance.
What do scientific studies say?
It’s important to be aware of what scientific studies claim and where their limitations lie. Salt therapy is not a miracle cure and does not replace medical treatment—but as a complementary therapy it may have beneficial effects.
2020 comprehensive literature review (13 studies)
Halotherapy may positively influence the condition of people with chronic airway diseases, including COPD. The researchers found that salt therapy improves mucociliary clearance, reduces airway inflammation, and improves pulmonary function measures such as FEV1 (forced expiratory volume in 1 second), FVC (forced vital capacity), and PEF (peak expiratory flow).3
2021 study – combination with medication
Combining halotherapy with conventional COPD medications (ambroxol and acetylcysteine) improved patients’ quality of life.4
2018 Russian study – occupational lung diseases
Improvement was reported in 90% of patients with mild occupational COPD after controlled halotherapy, and effectiveness was 85% in moderate cases.5
Limits of the scientific evidence
A 2014 systematic review—which examined 151 studies—concluded that there are currently few high‑quality randomized trials, so halotherapy can only be recommended as a complement to medical COPD treatment. 6 The researchers emphasize that further studies are needed. This does not mean that salt therapy doesn’t work—only that more scientific evidence is required.
Effects of salt therapy on COPD symptoms
In practice, many people with COPD report several benefits from using salt therapy. The most commonly reported effects are the following:
Easier mucus clearance is one of the most noticeable changes. The thick, sticky sputum that you might previously have coughed for hours becomes thinner and easier to expel with salt therapy. This provides substantial relief, especially in the morning when COPD patients usually have the most mucus.
Breathing becomes easier is another common experience. Although salt therapy does not directly dilate the bronchi like bronchodilator medications, by helping remove mucus and reducing inflammation it can indirectly improve breathing.
Reduction in exacerbation frequency is also observed in some patients. Regular salt therapy can help keep the airways clearer, potentially lowering the risk of infections and acute flare‑ups.
Improved overall well‑being should not be overlooked. When you breathe more easily and struggle with less mucus, your overall quality of life improves—you sleep better, can be more active, and worry less about the disease.
Different salt therapy methods in COPD
There are several forms of salt therapy, and it’s important to know which might be best for you.
Natural salt caves—like the Turda Salt Mine or the famous Wieliczka in Poland—have been used for healing for centuries. In the 1840s, Polish physician Feliks Boczkowski first observed that salt miners rarely suffered from respiratory diseases. The advantage of salt caves is the natural, clean environment with constant temperature and humidity. The downside is that you need to spend weeks there, which is not always feasible with COPD.
Artificial salt rooms try to replicate the conditions of salt caves. In Hungary, the salt chamber of the Szent Gellért Bath in Budapest holds a special place.1 In the inhalatorium established at the same time as the bath in 1918, patients inhaled a nebulized salt solution (table salt and baking soda in water) producing 0.5 micron droplets for 15–20 minutes. Currently it is closed for renovation, with reopening expected in 2028.
Home salt therapy devices, such as the SaltDome, make regular daily use possible at home. This is especially important in COPD, because most studies showed results with regular, longer‑term treatment—and not everyone can attend salt rooms several times a week.
Home salt therapy with the SaltDome device in COPD
SaltDome ultrasonic salt therapy device
The SaltDome is specifically designed for home use. The device nebulizes a salt solution ultrasonically and releases salt particles of 2–5 microns into the air—exactly the size range that reaches the lower airways where COPD does the most damage.
An advantage of the SaltDome over dry salt therapy devices is that it works with wet nebulization, so it does not dry out the airways. This is particularly important in COPD, because dry airways increase the cough reflex and worsen mucus clearance.
The device is designed for nighttime use: placed near your bed, it gently releases salty air for you to breathe while you sleep. Its noise level is low and does not disturb sleep. Regular use—6–8 hours nightly during sleep—may produce meaningful improvement in COPD symptoms.
My advice
If you have COPD and start home salt therapy, be patient. Most patients notice changes after 2–4 weeks, especially in mucus clearance. In the first days you may cough more—this is normal and a sign that mucus loosening has begun.
The role of salt therapy in COPD management
Important information
Salt therapy is a complementary treatment, not a replacement for medication. If you have COPD, your core treatment consists of inhalers and pulmonary rehabilitation—do not stop these because of salt therapy.
Think of salt therapy as an additional tool in your toolbox. Your prescribed medications dilate the airways and reduce inflammation. Salt therapy helps with mucus loosening, airway cleaning, and supporting overall airway health. Together they are more effective than either alone.
The “four pillars” of COPD management look like this: first, quitting smoking if you still smoke. Second, pharmacological treatment (inhalers). Third, pulmonary rehabilitation (breathing exercises, physical activity). Fourth, complementary therapies, including salt therapy.
Before you start treatment
Salt therapy is generally a safe method, but there are specific considerations for COPD that you should keep in mind. Consult your pulmonologist before starting salt therapy. Although halotherapy has a favorable side‑effect profile—most studies have not found serious adverse effects—your doctor knows your individual situation and can judge whether this complementary treatment is appropriate for you.
When not to use it?
- Acute COPD exacerbation – When your symptoms suddenly worsen, if you have a fever, or are taking antibiotics, wait until you recover. Salt therapy is useful during stable periods, not in the acute phase.
- Untreated high blood pressure – Although the amount of salt inhaled is a fraction of what you ingest through diet, caution is advised in severe, uncontrolled hypertension. Discuss salt therapy with your doctor.
- Severe heart failure – Salt therapy is not recommended.
- Active tuberculosis – Always consult your treating physician beforehand.
- Airway bleeding – Always consult your treating physician beforehand.
- Cancer – Always consult your treating physician beforehand.
Possible side effects
Side effects of salt therapy are generally mild and transient. The most common is a mild cough in the first days—this is actually a good sign, indicating that mucus is loosening and starting to move. Some people initially experience mild throat irritation.
With COPD, you may cough more and expectorate more mucus in the first few days. This is a normal reaction—the purpose of salt therapy is precisely this. However, if symptoms persistently worsen, you experience increased shortness of breath, or develop a fever, stop the treatment immediately and consult your doctor.
Expert opinion
Experts at Semmelweis University state that properly performed halotherapy does not have significant adverse effects.1
Practical tips for people with COPD
If you start home salt therapy, here are some practical tips for effective use.
Consistency
Consistency is more important than intensity. It’s better to use the device nightly at lower intensity than to “overdo” it once a week. Regeneration of the airway mucosa takes time—give your body time.
Combine with breathing exercises
Combine salt therapy with breathing exercises. In the morning after a night of salt therapy, perform controlled coughing exercises to effectively remove the loosened mucus. Diaphragmatic breathing and pursed‑lip exhalation also aid mucus clearance.
Fluid intake and maintenance
Pay attention to fluid intake. Proper hydration helps thin mucus. Drink at least 1.5–2 liters of water daily unless your doctor has advised fluid restriction for another reason.
Maintain the device according to the manufacturer’s instructions. Regular replacement of the salt solution and cleaning of the reservoir are important for hygiene and effective operation.
Symptom diary
Keep a symptom diary. Note changes in your cough, mucus, and breathing. This helps both you and your doctor evaluate the effect of salt therapy.
Summary – Quick overview
| Term | Meaning |
|---|---|
| COPD | Chronic obstructive pulmonary disease – a slowly progressive, chronic lung disease |
| Salt therapy / Halotherapy | Complementary therapy based on inhalation of salt particles |
| FEV1 | Forced expiratory volume in one second – a key pulmonary function metric |
| Exacerbation | An acute flare‑up of COPD, sudden worsening of symptoms |
| Mucociliary clearance | The mucus‑clearing function of airway cilia |
| NLRP3 inflammasome | An inflammatory pathway that salt therapy may inhibit |
Mechanism of action in COPD
Salt therapy acts through three main mechanisms in COPD. First, mucus loosening: salt particles dilute thick mucus by osmotic effects, making it easier to cough up. Second, anti‑inflammatory action: halotherapy inhibits activation of the NLRP3 inflammasome, reducing inflammatory factor levels. Third, cilia activation: it stimulates mucociliary clearance.
Frequently asked questions
No. Salt therapy is a complementary method to be used alongside medical treatment (inhalers, pulmonary rehabilitation), not instead of it.
Most patients notice changes after 2–4 weeks of regular use, especially in mucus clearance.
No. In the acute phase, wait until you recover—salt therapy is useful during stable periods.
For COPD, nighttime use is recommended: 6–8 hours nightly while sleeping.
Side effects are generally mild: temporary increase in coughing (a sign of mucus loosening) and mild throat irritation.
Detailed guides by condition
If a specific disease or condition interests you, read our detailed guides, where we present the possibilities of salt therapy supported by scientific research:
Sinusitis and salt therapy – Get rid of your sinusitis →
Asthma and salt therapy – Natural breathing support →
Cystic fibrosis and salt therapy – Mucus clearance and breathing support →
Common cold, flu and salt therapy – Faster recovery →
Hay fever and salt therapy – Relief of allergic symptoms →
Post‑pneumonia recovery – Salt therapy as a complementary treatment →
Snoring and salt therapy – How it can help free breathing? →
Dermatological issues and salt therapy – Complementary treatment for eczema and psoriasis →
Sources
- Semmelweis University, Department of Otorhinolaryngology and Head–Neck Surgery. Effects of salt therapy. semmelweis.hu
- Zhang Y, et al. (2023). Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis. Annals of Translational Medicine, 10(24):1319. PubMed: 36618788
- Barber D, et al. (2020). Halotherapy for Chronic Respiratory Disorders: From the Cave to the Clinical. Alternative Therapies in Health and Medicine. PubMed: 32827399
- (2021). Optimization of pathogenetic therapy in patients with chronic obstructive lung disease. Terapevticheskii Arkhiv.
- (2018). Efficiency of controlled halotherapy in rehabilitation of patients with occupational lung diseases. Meditsina Truda i Promyshlennaya Ekologiya. PubMed: 30351691
- Rashleigh R, Smith SM, Roberts NJ. (2014). A review of halotherapy for chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, 9:239-246. PubMed: 24591823
- Chervinskaya AV, Zilber NA. (1995). Halotherapy for treatment of respiratory diseases. Journal of Aerosol Medicine, 8(3):221-232. PubMed: 10161255
- Szabó K, et al. (2021). Salt Therapy as a Complementary Method for the Treatment of Respiratory Tract Diseases. International Journal of Environmental Research and Public Health. PubMed: 34726628
- Fu Q, et al. (2021). New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease. Journal of Inflammation Research, 14:4155-4168. PMC8405160